Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression

Journal of Experimental Medicine

Volumn 199, Issue 1, 2004, Pages 47-57

  Ueda, Yoshihiro ^a   Yang, Kaiyong ^a   Foster, Sandra J ^a   Kondo, Motonari ^a   Kelsoe, Garnett ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Hematopoiesis; Innate immunity; Neutrophilia; TNF

Indexed keywords

ALPHA CHEMOKINE; INTERLEUKIN 1BETA; PERTUSSIS TOXIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL COMPARTMENTALIZATION; CELL MATURATION; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HEMATOPOIESIS; INFLAMMATION; LYMPHOCYTE; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BONE MARROW CELLS; CHEMOKINES, CXC; COLONY-FORMING UNITS ASSAY; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STROMAL CELLS;

EID: 0347285361     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031104     Document Type: Article

References (57)

1. Young, N.S., B. Baranski, and G. Kurtzman. 1989. The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus. Ann. NY Acad. Sci. 554:75-80.
2. Apperley, J.F., C. Dowding, J. Hibbin, J. Buiter, E. Matutes, P.J. Sissons, M. Gordon, and J.M. Goldman. 1989. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 17:38-45.
3. Nagaoka, H., G. Gonzalez-Aseguinolaza, M. Tsuji, and M.C. Nussenzweig. 2000. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J. Exp. Med. 191:2113-2120.
4. Gartner, F., F.W. Alt, R.J. Monroe, and K.J. Seidl. 2000. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J. Exp. Med. 192:1745-1754.
5. Dorshkind, K. 1988. Interleukin-1 inhibition of B lymphopoiesis is reversible. Blood. 72:2053-2055.
6. Dorshkind, K. 1988. IL-1 inhibits B cell differentiation in long term bone marrow cultures. J. Immunol. 141:531-538.
7. Griffiths, S.D., D.T. Goodhead, S.J. Marsden, E.G. Wright, S. Krajewski, J.C. Reed, S.J. Korsmeyer, and M. Greaves. 1994. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J. Exp. Med. 179:1789-1797.
8. Lin, Q., C. Dong, and M.D. Cooper. 1998. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187:79-87.
9. Binder, D., J. Fehr, H. Hengartner, and R.M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-α /β during acute infection with the non-cytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185:517-530.
10. Wang, J., Q. Lin, H. Langston, and M.D. Cooper. 1995. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity. 3:475-484.
11. Gongora, R., R.P. Stephan, R.D. Schreiber, and M.D. Cooper. 2000. Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs. J. Immunol. 165:2362-2366.
12. Hikida, M., M. Mori, T. Takai, K. Tomochika, K. Hamatani, and H. Ohmori. 1996. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science. 274:2092-2094.
13. Han, S., B. Zheng, D.G. Schatz, E. Spanopoulou, and G. Kelsoe. 1996. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science. 274:2094-2097.
14. Hertz, M., V. Kouskoff, T. Nakamura, and D. Nemazee. 1998. V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling. Nature. 394:292-295.
15. Papavasiliou, F., R. Casellas, H. Suh, X.F. Qin, E. Besmer, R. Pelanda, D. Nemazee, K. Rajewsky, and M.C. Nussenzweig. 1997. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science. 278:298-301.
16. Meffre, E., F. Papavasiliou, P. Cohen, O. de Bouteiller, D. Bell, H. Karasuyama, C. Schiff, J. Banchereau, Y.J. Liu, and M.C. Nussenzweig. 1998. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J. Exp. Med. 188:765-772.
17. Han, S., S.R. Dillon, B. Zheng, M. Shimoda, M.S. Schlissel, and G. Kelsoe. 1997. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science. 278:301-305.
18. Monroe, R.J., K.J. Seidl, F. Gaertner, S. Han, F. Chen, J. Sekiguchi, J. Wang, R. Ferrini, L. Davidson, G. Kelsoe, and F.W. Alt. 1999. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity. 11:201-212.
19. Yu, W., H. Nagaoka, M. Jankovic, Z. Misulovin, H. Suh, A. Rolink, F. Melchers, E. Meffre, and M.C. Nussenzweig. 1999. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature. 400:682-687.
20. Cyster, J.G., and C.C. Goodnow. 1995. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J. Exp. Med. 182:581-586.
21. Marino, M.W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:8093-8098.
22. Tacchini-Cottier, F., C. Vesin, M. Redard, W. Buurman, and P.F. Piguet. 1998. Role of TNFR1 and TNFR2 in TNF-induced platelet consumption in mice. J. Immunol. 160:6182-6186.
23. Chen, Z., S.B. Koralov, M. Gendelman, M.C. Carroll, and G. Kelsoe. 2000. Humoral immune responses in Cr2-/-mice: enhanced affinity maturation but impaired antibody persistence. J. Immunol. 164:4522-4532.
24. Rolink, A.G., J. Andersson, and F. Melchers. 1998. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 28:3738-3748.
25. Norsworthy, P., E. Theodoridis, M. Botto, P. Athanassiou, H. Beynon, C. Gordon, D. Isenberg, M.J. Walport, and K.A. Davies. 1999. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum. 42:1828-1832.
26. Petrenko, O., A. Beavis, M. Klaine, R. Kittappa, I. Godin, and I.R. Lemischka. 1999. The molecular characterization of the fetal stem cell market AA4. Immunity. 10:691-700.
27. McGreal, E.P., N. Ikewaki, H. Akatsu, B.P. Morgan, and P. Gasque. 2002. Human C1qRp is identical with CD93 and the mN1-11 antigen but does not bind C1q. J. Immunol. 168:5222-5232.
28. Hestdal, K., F.W. Ruscetti, J.N. Ihle, S.E. Jacobsen, C.M. Dubois, W.C. Kopp, D.L. Longo, and J.R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:22-28.
29. Loder, F., B. Mutschler, R. Ray, C. Paige, P. Sideras, R. Torres, M. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75-89.
30. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:635-638.
31. Ma, Q., D. Jones, P.R. Borghesani, R.A. Segal, T. Nagasawa, T. Kishimoto, R.T. Bronson, and T.A. Springer. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA. 95:9448-9453.
32. Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595-599.
33. Ma, Q., D. Jones, and T.A. Springer. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 10:463-471.
34. + progenitors to peripheral blood. J. Exp. Med. 185:111-120.
35. Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R.S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-694. (published erratum in Nat. Immunol. 2002. 3:787)
36. Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R.S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-694. (published erratum in Nat. Immunol. 2002. 3:787)
37. Tashiro, K., H. Tada, R. Heilker, M. Shirozu, T. Nakano, and T. Honjo. 1993. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science. 261:600-603.
38. Fedyk, E.R., D. Jones, H.O. Critchley, R.P. Phipps, T.M. Blieden, and T.A. Springer. 2001. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J. Immunol. 166:5749-5754.
39. McQuibban, G.A., G.S. Butler, J.H. Gong, L. Bendall, C. Power, I. Clark-Lewis, and C.M. Overall. 2001. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276:43503-43508.
40. Delgado, M.B., I. Clark-Lewis, P. Loetscher, H. Langen, M. Thelen, M. Baggiolini, and M. Wolf. 2001. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur. J. Immunol. 31:699-707.
41. Ulich, T.R., J. del Castillo, R.X. Ni, and N. Bikhazi. 1989. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats. J. Leukoc. Biol. 45:546-557.
42. Bleul, C.C., R.C. Fuhlbrigge, J.M. Casasnovas, A. Aiuti, and T.A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101-1109.
43. Delgado, E., V. Finkel, M. Baggiolini, C.R. Mackay, R.M. Steinman, and A. Granelli-Piperno. 1998. Mature dendritic cells respond to SDF-1, but not to several beta-chemokines. Immunobiology. 198:490-500.
44. Broxmeyer, H.E., B.S. Youn, C. Kim, G. Hangoc, S. Cooper, and C. Mantel. 2001. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G alpha i proteins. Ann. NY Acad. Sci. 938:117-127; discussion 127-128.
45. Kim, C.H., and H.E. Broxmeyer. 1998. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 91:100-110.
46. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242.
47. Zaballos, A., J. Gutierrez, R. Varona, C. Ardavin, and G. Marquez. 1999. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J. Immunol. 162:5671-5675.
48. Nakayama, T., K. Hieshima, D. Izawa, Y. Tatsumi, A. Kanamaru, and O. Yoshie. 2003. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J. Immunol. 170:1136-1140.
49. Wilbanks, A., S.C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D.P. Andrew, L. Wu, and M. Briskin. 2001. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166:5145-5154.
50. Diacovo, T.G., S.J. Roth, J.M. Buccola, D.F. Bainton, and T.A. Springer. 1996. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood. 88:146-157.
51. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7:625-655.
52. Dorshkind, K. 1991. In vivo administration of recombinant granulocyte-macrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis. J. Immunol. 146:4204-4208.
53. Damia, G., K.L. Komschlies, C.R. Faltynek, F.W. Ruscetti, and R.H. Wiltrout. 1992. Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood. 79:1121-1129.
54. Grzegorzewski, K., K.L. Komschlies, M. Mori, K. Kaneda, N. Usui, C.R. Faltynek, J.R. Keller, F.W. Ruscetti, and R.H. Wiltrout. 1994. Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. Blood. 83:377-385.
55. Engle, W.D., and C.R. Rosenfeld. 1984. Neutropenia in high-risk neonates. J. Pediatr. 105:982-986.
56. Gessler, P., R. Luders, S. Konig, N. Haas, P. Lasch, and W. Kachel. 1995. Neonatal neutropenia in low birthweight pre-mature infants. Am. J. Perinatol. 12:34-38.
57. Meffre, E., E. Davis, C. Schiff, C. Cunningham-Rundles, L.B. Ivashkiv, L.M. Staudt, J.W. Young, and M.C. Nussenzweig. 2000. Circulating human B cells that express surrogate light chains and edited receptors. Nat. Immunol. 1:207-213.